{"id":1583,"date":"2001-06-01T12:06:00","date_gmt":"2001-06-01T10:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/ace-hemmer-sind-nicht-wirksam-zur-prophylaxe-einer-restenose-nach-koronarer-stent-implanation-die-paris-studie"},"modified":"2001-06-01T12:06:00","modified_gmt":"2001-06-01T10:06:00","slug":"ace-hemmer-sind-nicht-wirksam-zur-prophylaxe-einer-restenose-nach-koronarer-stent-implanation-die-paris-studie","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2001\/ace-hemmer-sind-nicht-wirksam-zur-prophylaxe-einer-restenose-nach-koronarer-stent-implanation-die-paris-studie","title":{"rendered":"ACE-Hemmer sind nicht wirksam zur Prophylaxe einer Restenose nach koronarer Stent-Implanation. Die PARIS-Studie"},"content":{"rendered":"<p>Eine franz\u00f6sische Gruppe untersuchte in einer monozentrischen und vom Hersteller finanzierten Studie, ob sich durch die Gabe des ACE-Hemmers Quinapril die H\u00e4ufigkeit koronarer Restenosierungen nach PTCA mit Stent-Implantation weiter verringern l\u00e4\u00dft (Meurice, T., et al. [PARIS = Prevention with ACE-inhibitors of angiographic RestenosIs after coronary Stenting]: Lancet 2001, 357, 1321). Hierzu wurden aus 546 konsekutiven [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eine franz\u00f6sische Gruppe untersuchte in einer monozentrischen und vom Hersteller finanzierten Studie, ob sich durch die Gabe des ACE-Hemmers Quinapril die H\u00e4ufigkeit koronarer Restenosierungen nach PTCA mit Stent-Implantation weiter verringern l\u00e4\u00dft (Meurice, T., et al. [PARIS = Prevention with ACE-inhibitors of angiographic RestenosIs after coronary Stenting]: Lancet 2001, 357, 1321). Hierzu wurden aus 546 konsekutiven [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[130,1172,3701,1630,882],"class_list":["post-1583","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-ace-hemmer","tag-koronar-stent","tag-paris-studie","tag-quinapril","tag-stent"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1583","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1583"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1583\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1583"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1583"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}